Why the study?
The use of pLVAD devices during complex high-risk PCI with reduced LVEF is considered a promising option for patients disqualified from surgery.
Does the Impella pump improve clinical outcomes compared to an intra-aortic balloon in patients undergoing complex high-risk PCI with reduced LVEF?
Does the Impella pump improve clinical outcomes compared to an intra-aortic balloon in patients undergoing complex high-risk PCI with reduced LVEF?
Preliminary single-center data suggests pLVAD devices are a promising option for high-risk PCI in patients with reduced LVEF who are ineligible for surgery.
Answers are grounded in this paper and cite their sources.
Supports pLVAD consideration in select high-risk PCI with reduced LVEF; hypothesis-generating and requires randomized confirmation.
The use of pLVAD devices in patients undergoing complex high-risk PCIs, with reduced left ventricular ejection fraction, is a promising treatment option for patients disqualified from surgery by cardiac surgeons.
No takes yet. Share an insight, caveat, or question.
Januszek et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: